Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α
Lavinia Nardinocchi(Istituto Dermopatico dell'Immacolata), Gabriella D’Orazi(University of Chieti-Pescara)
Cited by 49
Related Papers
Interleukin‐17 and interleukin‐22 promote tumor progression in human nonmelanoma skin cancer
|European Journal of Immunology|2014|96
Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy
|Cell Death and Disease|2013|43
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status
|Journal of Experimental & Clinical Cancer Research|2020|32